Clinical Trials Browser

Phase 1/2 × Withdrawn × tocilizumab × Clear all

NCT02997956 2017-04-25

Study of Tocilizumab in Patients With Hepatocellular Carcinoma (HCC) Undergoing Transarterial Chemoembolization (TACE)

Phase 1/2 Withdrawn

Gastrointestinal

Carcinoma, Hepatocellular